Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 10%

Bulls say

HealthEquity is the largest provider of healthcare savings solutions in the United States and is well-positioned to capitalize on the growing market. The company's business model aligns with current trends in the healthcare market, such as the increasing use of high deductible health plans, which expands HealthEquity's total addressable market. With a strong track record of outpacing the overall healthcare savings market and a growing potential customer base, HealthEquity has the potential for continued growth. Additionally, the company's investments in technology, such as its mobile app with over 1.4 million monthly active users and its new investing product SimplyInvest, show a commitment to providing a comprehensive and convenient healthcare solution for consumers. However, the company faces risks such as increasing competition in the industry, changing regulations and laws, and reliance on third-party suppliers and employees. Overall, HealthEquity has a positive outlook, and we rate the stock as BUY.

Bears say

HealthEquity is facing several fundamental challenges that could hinder its growth potential. These include increasing competition in the healthcare industry, growing popularity of alternative payment methods, and a slow post-pandemic recovery. Additionally, the company is currently facing a class action lawsuit and incurring costs due to a recent fraud attack, which could negatively affect its financial performance. Furthermore, the company's dependence on technology and AI to drive down costs may not be enough to offset potential decreases in interest rates or investment returns. Also worth noting is the company's high valuation, with a current trading multiple that is above its 5-year average.

HealthEquity (HQY) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 10 analysts, HealthEquity (HQY) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $113.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $113.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.